Skip to content

Application of human acellular dermal marx (HADM) in oral soft tissue augmentation

Application of human acellular dermal marx (HADM) in oral soft tissue augmentation - Application of human acellular dermal marx (HADM) in oral soft tissue augmentation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093884
Enrollment
Unknown
Registered
2024-12-13
Start date
2024-12-18
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Soft tissue deficiency

Interventions

Experimental group of keratinized gingiva augmentation:keratinized gingiva augmentation with HADM
Control group of keratinized gingiva augmentation:None
Experimental group of alveolar ridge preservation:Alveolar ridge preservation with HADM
Control group of alveolar ridge preservation:None
Experimental group of peri-implant soft tissue augment:Peri-implant soft tissue augment with HADM

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Experiment 1: 1) patients aged >=18 years old, healthy in the past, without complaints of systemic diseases; 2) insufficient keratinized gingiva; 3) no acute periodontal inflammation; 4) no infection of soft tissue wound; 5) Patients had good compliance; 6) agree to participate in this clinical trial and sign the informed consent. Experiment 2: 1) 18=3mm; 4) no acute periodontal inflammation; 5) those with good compliance and can cooperate to complete the whole clinical trial; 6) able to understand the purpose of the trial, voluntarily participate and sign informed consent. Experiment 3: 1) 18 years old <= age <=70 years old, regardless of gender; 2) patients with labial and buccal gingival depression requiring soft tissue augmentation in the second stage of implant placement. 3) no acute periodontal inflammation; 4) those with good compliance and can cooperate to complete the whole clinical trial; 5) able to understand the purpose of the trial, voluntarily participate and sign informed consent

Exclusion criteria

Exclusion criteria: (1) Acute infection of affected teeth or adjacent teeth and soft tissues (2) female patients during pregnancy or lactation (3) taking drugs affecting platelet or bone regeneration within 3 months (4) patients with a history of head and neck radiotherapy and uncontrolled systemic diseases (5) heavy smokers, smoking more than 10 cigarettes/day.

Design outcomes

Primary

MeasureTime frame
Keratinized gingival width at 6 months after surgery;

Secondary

MeasureTime frame
Keratinized gingival width at 3 months after surgery;

Countries

China

Contacts

Public ContactFan Yang

Zhejiang Provincial People's Hospital

yangfan@hmc.edu.cn+86 571 8589 3206

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026